183 related articles for article (PubMed ID: 20641034)
21. The molecular biology of parathyroid disease.
Backdahl M; Howe JR; Lairmore TC; Wells SA
World J Surg; 1991; 15(6):756-62. PubMed ID: 1685045
[TBL] [Abstract][Full Text] [Related]
22. [Cyclin D1 in sporadic parathyroid adenomas].
Imanishi Y
Clin Calcium; 2001 Dec; 11(12):1637-41. PubMed ID: 15775480
[TBL] [Abstract][Full Text] [Related]
23. Splenic lymphoma with villous lymphocytes: analysis of BCL-1 rearrangements and expression of the cyclin D1 gene.
Jadayel D; Matutes E; Dyer MJ; Brito-Babapulle V; Khohkar MT; Oscier D; Catovsky D
Blood; 1994 Jun; 83(12):3664-71. PubMed ID: 8204891
[TBL] [Abstract][Full Text] [Related]
24. Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate.
Tahara H; Smith AP; Gaz RD; Zariwala M; Xiong Y; Arnold A
J Bone Miner Res; 1997 Sep; 12(9):1330-4. PubMed ID: 9286748
[TBL] [Abstract][Full Text] [Related]
25. The t(2;3)(q21;q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5' regulatory region and chromosomal breakpoints distant from the gene.
Chen W; Butler M; Rao PH; Chaganti SR; Louie DC; Dalla-Favera R; Chaganti RS
Oncogene; 1998 Oct; 17(13):1717-22. PubMed ID: 9796700
[TBL] [Abstract][Full Text] [Related]
26. Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene.
de Boer CJ; Loyson S; Kluin PM; Kluin-Nelemans HC; Schuuring E; van Krieken JH
Cancer Res; 1993 Sep; 53(18):4148-52. PubMed ID: 8364907
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D1 activation in B-cell malignancy: association with changes in histone acetylation, DNA methylation, and RNA polymerase II binding to both promoter and distal sequences.
Liu H; Wang J; Epner EM
Blood; 2004 Oct; 104(8):2505-13. PubMed ID: 15226187
[TBL] [Abstract][Full Text] [Related]
28. Molecular cloning of IGλ rearrangements using long-distance inverse PCR (LDI-PCR).
Shimanuki M; Sonoki T; Hosoi H; Watanuki J; Murata S; Kawakami K; Matsuoka H; Hanaoka N; Nakakuma H
Eur J Haematol; 2013 Jan; 90(1):59-67. PubMed ID: 23113889
[TBL] [Abstract][Full Text] [Related]
29. Multiple genetic aberrations including evidence of chromosome 11q13 rearrangement detected in pituitary adenomas by comparative genomic hybridization.
Metzger AK; Mohapatra G; Minn YA; Bollen AW; Lamborn K; Waldman FM; Wilson CB; Feuerstein BG
J Neurosurg; 1999 Feb; 90(2):306-14. PubMed ID: 9950502
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas.
Ikeda S; Ishizaki Y; Shimizu Y; Fujimori M; Ojima Y; Okajima M; Sugino K; Asahara T
Int J Oncol; 2002 Mar; 20(3):463-6. PubMed ID: 11836555
[TBL] [Abstract][Full Text] [Related]
31. Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas.
Arya AK; Bhadada SK; Singh P; Sachdeva N; Saikia UN; Dahiya D; Behera A; Bhansali A; Rao SD
Sci Rep; 2017 Jun; 7(1):3123. PubMed ID: 28600574
[TBL] [Abstract][Full Text] [Related]
32. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
[TBL] [Abstract][Full Text] [Related]
33. CDK4/6 Dependence of Cyclin D1-Driven Parathyroid Neoplasia in Transgenic Mice.
Costa-Guda J; Corrado K; Bellizzi J; Romano R; Saria E; Saucier K; Rose M; Shah S; Alander C; Mallya S; Arnold A
Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32877917
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression.
Hosokawa Y; Arnold A
Genes Chromosomes Cancer; 1998 May; 22(1):66-71. PubMed ID: 9591636
[TBL] [Abstract][Full Text] [Related]
35. Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies.
Raynaud SD; Bekri S; Leroux D; Grosgeorge J; Klein B; Bastard C; Gaudray P; Simon MP
Genes Chromosomes Cancer; 1993 Oct; 8(2):80-7. PubMed ID: 7504521
[TBL] [Abstract][Full Text] [Related]
36. CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma.
Sukov WR; Ketterling RP; Lager DJ; Carlson AW; Sinnwell JP; Chow GK; Jenkins RB; Cheville JC
Hum Pathol; 2009 Sep; 40(9):1296-303. PubMed ID: 19386349
[TBL] [Abstract][Full Text] [Related]
37. Parathyroid hormone/parathyroid hormone related peptide receptor gene transcripts are expressed from tissue-specific and ubiquitous promoters.
McCuaig KA; Lee HS; Clarke JC; Assar H; Horsford J; White JH
Nucleic Acids Res; 1995 Jun; 23(11):1948-55. PubMed ID: 7596823
[TBL] [Abstract][Full Text] [Related]
38. Comparative sequence analysis of the Gdf6 locus reveals a duplicon-mediated chromosomal rearrangement in rodents and rapidly diverging coding and regulatory sequences.
Mortlock DP; Portnoy ME; Chandler RL; ; Green ED
Genomics; 2004 Nov; 84(5):814-23. PubMed ID: 15475260
[TBL] [Abstract][Full Text] [Related]
39. Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes.
Vaandrager JW; Schuuring E; Raap T; Philippo K; Kleiverda K; Kluin P
Genes Chromosomes Cancer; 2000 Jan; 27(1):85-94. PubMed ID: 10564590
[TBL] [Abstract][Full Text] [Related]
40. Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangement.
Williams ME; Swerdlow SH
Ann Oncol; 1994; 5 Suppl 1():71-3. PubMed ID: 8172823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
